These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 23038793

  • 1. Fluconazole inhibits human adrenocortical steroidogenesis in vitro.
    van der Pas R, Hofland LJ, Hofland J, Taylor AE, Arlt W, Steenbergen J, van Koetsveld PM, de Herder WW, de Jong FH, Feelders RA.
    J Endocrinol; 2012 Dec; 215(3):403-12. PubMed ID: 23038793
    [Abstract] [Full Text] [Related]

  • 2. Effects of ACTH on steroidogenesis in bovine adrenocortical cells in primary culture--increased secretion of 17 alpha-hydroxylated steroids associated with a refractoriness in total steroid output.
    Kramer RE, McCarthy JL, Simpson ER, Waterman MR.
    J Steroid Biochem; 1983 Jun; 18(6):715-23. PubMed ID: 6306344
    [Abstract] [Full Text] [Related]

  • 3. Differential effects of the imidazole derivatives etomidate, ketoconazole and miconazole and of metyrapone on the secretion of cortisol and its precursors by human adrenocortical cells.
    Lamberts SW, Bons EG, Bruining HA, de Jong FH.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):259-64. PubMed ID: 3027305
    [Abstract] [Full Text] [Related]

  • 4. Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11 beta-hydroxylase.
    Engelhardt D, Dörr G, Jaspers C, Knorr D.
    Klin Wochenschr; 1985 Jul 01; 63(13):607-12. PubMed ID: 2993735
    [Abstract] [Full Text] [Related]

  • 5. Autocrine positive regulatory feedback of glucocorticoid secretion: glucocorticoid receptor directly impacts H295R human adrenocortical cell function.
    Asser L, Hescot S, Viengchareun S, Delemer B, Trabado S, Lombès M.
    Mol Cell Endocrinol; 2014 Sep 01; 395(1-2):1-9. PubMed ID: 25058354
    [Abstract] [Full Text] [Related]

  • 6. On the specificity of the inhibitory effect of trilostane and aminoglutethimide on adrenocortical steroidogenesis in guinea pig.
    Lambert F, Corcelle-Cerf F, Lammerant J, Kolanowski J.
    Mol Cell Endocrinol; 1984 Aug 01; 37(1):115-20. PubMed ID: 6088327
    [Abstract] [Full Text] [Related]

  • 7. Osilodrostat Is a Potential Novel Steroidogenesis Inhibitor for the Treatment of Cushing Syndrome: An In Vitro Study.
    Creemers SG, Feelders RA, de Jong FH, Franssen GJH, de Rijke YB, van Koetsveld PM, Hofland LJ.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3437-3449. PubMed ID: 31127821
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor beta1 inhibits aldosterone and cortisol production in the human adrenocortical cell line NCI-H295R through inhibition of CYP11B1 and CYP11B2 expression.
    Liakos P, Lenz D, Bernhardt R, Feige JJ, Defaye G.
    J Endocrinol; 2003 Jan 01; 176(1):69-82. PubMed ID: 12525251
    [Abstract] [Full Text] [Related]

  • 9. Close examination of steroidogenesis disorders in a DOC- and progesterone-producing adrenocortical carcinoma.
    Sone M, Shibata H, Homma K, Tamura N, Akahira J, Hamada S, Yahata M, Fukui N, Itoh H, Sasano H, Nakao K.
    Endocrine; 2009 Feb 01; 35(1):25-33. PubMed ID: 18985457
    [Abstract] [Full Text] [Related]

  • 10. Levoketoconazole, the 2S,4R Enantiomer of Ketoconazole, a New Steroidogenesis Inhibitor for Cushing's Syndrome Treatment.
    Creemers SG, Feelders RA, de Jong FH, Franssen GJH, de Rijke YB, van Koetsveld PM, Hofland LJ.
    J Clin Endocrinol Metab; 2021 Mar 25; 106(4):e1618-e1630. PubMed ID: 33399817
    [Abstract] [Full Text] [Related]

  • 11. In vitro effects of genistein and daidzein on the activity of adrenocortical steroidogenic enzymes in mature female pigs.
    Kaminska B, Ciereszko R, Kiezun M, Dusza L.
    J Physiol Pharmacol; 2013 Feb 25; 64(1):103-8. PubMed ID: 23568977
    [Abstract] [Full Text] [Related]

  • 12. Steroid content of the peripheral and adrenal vein in Cushing's syndrome due to adrenocortical adenoma and carcinoma.
    Levine AC, Mitty HA, Gabrilove JL.
    J Urol; 1988 Jul 25; 140(1):11-5. PubMed ID: 2967899
    [Abstract] [Full Text] [Related]

  • 13. An adrenocortical tumor secreting weak mineralocorticoids.
    Makino K, Yasuda K, Okuyama M, Ojima M, Sasano N, Miura K.
    Endocrinol Jpn; 1987 Feb 25; 34(1):65-72. PubMed ID: 3608914
    [Abstract] [Full Text] [Related]

  • 14. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
    Midorikawa S, Sanada H, Hashimoto S, Suzuki T, Watanabe T, Sasano H.
    Endocr J; 2001 Apr 25; 48(2):167-74. PubMed ID: 11456263
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adrenocortical hyperresponsivity to adrenocorticotropic hormone: a mechanism favoring the normal production of cortisol in 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Huerta R, Dewailly D, Decanter C, Knochenhauer ES, Boots LR, Azziz R.
    Fertil Steril; 2000 Aug 25; 74(2):329-34. PubMed ID: 10927053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.